Research programme: estradiol vaginal foam - Foamix
Alternative Names: Estradiol hemihydrate foam - FoamixLatest Information Update: 13 Mar 2020
At a glance
- Originator Foamix
- Class Estradiol congeners; Estrenes; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Atrophic vaginitis
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 28 Aug 2018 No recent reports of development identified for preclinical development in Atrophic-vaginitis in Israel (Vaginal, Foam)
- 02 Jul 2014 Estradiol vaginal foam - Foamix is available for licensing. http://www.foamix.co.il